Endoscopic and Clinical Variables That Predict Sustained Remission in Children With Ulcerative Colitis Treated With Infliximab

Turner, Dan; Griffiths, Anne M.; Veerman, Gigi; Johanns, Jewel; Damaraju, Lakshmi; Blank, Marion; Hyams, Jeffrey S.

doi:10.1016/j.cgh.2013.04.049

Cited by 59 publications

(54 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Thus, this level could become a therapeutic target for physicians treating CD patients who are in clinical remission when attending the outpatient clinic (28) . Therefore, FC determination can also be used to predict flares of IBD (6,8) .…”

Section: Discussionmentioning

confidence: 99%

FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms

Kotze

Nisihara

Marion

et al. 2015

Arq. Gastroenterol.

View full text Add to dashboard Cite

-Background -Determination of fecal calprotectin can provide an important guidance for the physician, also in primary care, in the differential diagnosis of gastrointestinal disorders, meanly between inflammatory bowel diseases and irritable bowel syndrome. Objectives -The aims of the present study were to prospectively investigate, in Brazilian adults with gastrointestinal complaints, the value of fecal calprotectin as a biomarker for the differential diagnosis between functional and organic disorders and to correlate the concentrations with the activity of inflammatory bowel diseases. Methods -The study included consecutive patients who had gastrointestinal complaints in which the measurement levels of fecal calprotectin were recommended. Fecal calprotectin was measured using a Bühlmann (Basel, Switzerland) ELISA kit.

show abstract

Section: Discussionmentioning

confidence: 99%

FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms

Kotze

Nisihara

Marion

et al. 2015

Arq. Gastroenterol.

View full text Add to dashboard Cite

show abstract

“…Although some clinical trials applied these indices (6), (7), there are only a limited number of reports available with activity indices in a population-based paediatric IBD cohort (8), (9).…”

confidence: 99%

Baseline Characteristics and Disease Phenotype in Inflammatory Bowel Disease

Müller

Lakatos

Kovács

et al. 2016

J. pediatr. gastroenterol. nutr.

View full text Add to dashboard Cite

show abstract

“…Indeed, a recent post hoc analysis of the T-72 infliximab trial in children with UC showed that clinical remission (judged by the PUCAI) was not inferior to sigmoidoscopy in predicting 1-year steroid-free sustained remission 13. Moreover, repeated endoscopic assessments in the research setting is challenging in children who most often require anaesthesia even for a limited sigmoidoscopy, for ethical and feasibility reasons.…”

Section: Discussionmentioning

confidence: 99%

Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee

Ruemmele

Hyams

Otley

et al. 2014

Gut

Self Cite

View full text Add to dashboard Cite

show abstract

Endoscopic and Clinical Variables That Predict Sustained Remission in Children With Ulcerative Colitis Treated With Infliximab

Cited by 59 publications

References 24 publications

FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms

FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms

Baseline Characteristics and Disease Phenotype in Inflammatory Bowel Disease

Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee

Contact Info

Product

Resources

About